RESEARCHER PROFILE

Hasan Ali Farhan

← Back to Iraqi Board for Medical Specializations

H

Iraqi Board for Medical Specializations

Cardiovascular Issues in PregnancyAcute Myocardial Infarction ResearchCoronary Interventions and DiagnosticsCardiovascular Function and Risk FactorsTakotsubo Cardiomyopathy and Associated Phenomena

Hasan Ali Farhan works in Cardiovascular Issues in Pregnancy, Acute Myocardial Infarction Research, Coronary Interventions and Diagnostics, Cardiovascular Function and Risk Factors, Takotsubo Cardiomyopathy and Associated Phenomena. Recorded institutional associations include University of Baghdad, Mustansiriyah University, Baghdad Medical City.

132Publications
1,012Citations
20H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update

    2021 · 89 citations
  2. Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology

    2021 · 84 citations
  3. Pregnant Women With Uncorrected Congenital Heart Disease

    2019 · 55 citations
  4. Dyslipidaemia in the Middle East: Current status and a call for action

    2016 · 51 citations
  5. Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry

    2021 · 45 citations
  6. Bromocriptine treatment and outcomes in peripartum cardiomyopathy: the EORP PPCM registry

    2024 · 41 citations
  7. Outcomes at One Year in Women with Peripartum Cardiomyopathy: Findings from the ESC EORP PPCM Registry

    2023 · 35 citations
  8. A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry

    2024 · 34 citations
  9. Pregnancy with a prosthetic heart valve, thrombosis, and bleeding: the ESC EORP Registry of Pregnancy and Cardiac disease III

    2025 · 33 citations
  10. Pregnancy Outcomes in Women After Arterial Switch Operation for Transposition of the Great Arteries: Results From ROPAC (Registry of Pregnancy and Cardiac Disease) of the European Society of Cardiology EURObservational Research Programme

    2020 · 29 citations
  11. Trends in the burden and determinants of hypertensive heart disease in the Eastern Mediterranean region, 1990–2019: an analysis of the Global Burden of Disease Study 2019

    2023 · 28 citations
  12. Peripartum cardiomyopathy

    2025 · 27 citations
  13. Pregnancies in women after peri-partum cardiomyopathy: the global European Society of Cardiology EuroObservational Research Programme Peri-Partum Cardiomyopathy Registry

    2025 · 27 citations
  14. Socio-economic factors determine maternal and neonatal outcomes in women with peripartum cardiomyopathy: A study of the ESC EORP PPCM registry

    2023 · 22 citations
  15. Proteomic Profiling in Patients With Peripartum Cardiomyopathy

    2023 · 21 citations
  16. Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology

    2023 · 21 citations
  17. Care of patients with ST-elevation myocardial infarction: an international analysis of quality indicators in the acute coronary syndrome STEMI Registry of the EURObservational Research Programme and ACVC and EAPCI Associations of the European Society of Cardiology in 11 462 patients

    2022 · 20 citations
  18. Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry

    2022 · 20 citations
  19. Clopidogrel non-responsiveness in patients undergoing percutaneous coronary intervention using the VerifyNow test: frequency and predictors

    2017 · 17 citations
  20. Outcomes of heart failure with reduced, mildly reduced, or preserved ejection fraction: the ESC HF III registry

    2025 · 16 citations
  21. Pregnancy outcomes in women with heritable thoracic aortic disease: data from the EORP ESC registry of pregnancy and cardiac disease (ROPAC) III

    2025 · 16 citations
  22. The burden of ischemic heart disease and the epidemiologic transition in the Eastern Mediterranean Region: 1990–2019

    2023 · 15 citations
  23. Impact of Earthquake on Cardiovascular Health: What Should Cardiovascular Healthcare Providers Anticipate After the Devastating Earthquakes in Turkey and Syria?

    2023 · 15 citations
  24. Congenital heart disease in the ESC EORP Registry of Pregnancy and Cardiac disease (ROPAC)

    2021 · 14 citations
  25. Living with Peripartum Cardiomyopathy: A Statement from the Heart Failure Association and the Association of Cardiovascular Nursing and Allied Professions of the European Society of Cardiology

    2024 · 13 citations
  26. Cardiovascular drug interventions in the cardio-oncology clinic by a cardiology pharmacist: ICOP-Pharm study

    2022 · 13 citations
  27. Women in cardiology: critical status and a call to move forward

    2020 · 11 citations
  28. Heart disease in pregnancy—clinical pattern and prevalence: initial data from the first cardio-maternal unit in Iraq

    2019 · 11 citations
  29. The ESC ACCA EAPCI EORP acute coronary syndrome ST-elevation myocardial infarction registry

    2019 · 10 citations
  30. Perceptions of the Cardiologists and Oncologists: Initial Step for Establishing Cardio-Oncology Service

    2021 · 8 citations
  31. Peripartum Cardiomyopathy in Iraq: Initial Registry-Based Data and 6 Month Outcomes

    2021 · 8 citations
  32. Cardiac amyloidosis: A survey of current awareness, diagnostic modalities, treatment practices, and clinical challenges among cardiologists in selected Middle Eastern countries

    2023 · 7 citations
  33. Cardiovascular Impacts of COVID-19 Pandemic: From Presentation to Management: Current and Future Perspectives

    2020 · 7 citations
  34. ICOP-Pharm: could the new paradigm bridge a gap in evidence raised by 2022 ESC guidelines on cardio-oncology?

    2022 · 5 citations
  35. Non-ST elevation acute coronary syndromes; clinical landscape, management strategy and in-hospital outcomes: an age perspective

    2021 · 5 citations
  36. COVID-19 Pandemic Impact on Physicians’ Decision-making: Digoxin Toxicity in View of Combination of Hydroxychloroquine and Azithromycin: A Case Report

    2020 · 5 citations
  37. Dropping risk stratification with subsequent treatment-risk paradox in non ST elevation acute coronary syndromes: a clinical audit in Iraq

    2021 · 4 citations
  38. Biomarker profile and risk stratification in cardiovascular disease during pregnancy: Action to move forward

    2021 · 4 citations
  39. TCT CONNECT-224 Interventional Cardiology Fellowship Training During COVID-19 Pandemic: Facts and Challenges

    2020 · 4 citations
  40. REGISTRIES FOR CARDIAC DISEASE IN PREGNANCY: AN EFFECTIVE TOOL FOR ORGANIZING MULTIDISCIPLINARY TEAM WITH BETTER OUTCOMES

    2018 · 4 citations
  41. Access to medical care globally for patients with peripartum cardiomyopathy: a clinical consensus statement of the Heart Failure Association of the ESC

    2026 · 3 citations
  42. Cardiovascular outcomes and aortic growth in pregnant women with Turner syndrome: data from the European Society of Cardiology EURObservational Research Programme Registry of Pregnancy and Cardiac Disease (ROPAC) III

    2025 · 3 citations
  43. Pilot phase of Iraqi Registry of Cardiovascular Diseases in Women: Assessing the Feasibility of Large Data Registry in Absence of Funding

    2025 · 3 citations
  44. Valve replacement during pregnancy: literature review including new data from the Registry Of Pregnancy And Cardiac disease III

    2025 · 3 citations
  45. Perceptions of Cardiovascular Healthcare Professionals Regarding Clinical Trials: A Survey-Based Study from the Middle East

    2025 · 3 citations
  46. Setting up a clinical service for PPCM in Iraq

    2021 · 3 citations
  47. ROLE OF CARDIOLOGY CLINICAL PHARMACIST IN PREVENTING HARMFUL ERRORS REACHING PATIENTS AT CARDIAC CARE UNIT

    2020 · 3 citations
  48. Clinical features, socioeconomic status, management, short and long-term outcomes of patients with acute myocardial infarction: Phase I results of PEACE MENA registry

    2024 · 2 citations
  49. INTERVENTIONS BY THE CARDIOLOGY CLINICAL PHARMACIST AT THE CARDIO-ONCOLOGY CLINIC

    2022 · 2 citations
  50. Left ventricular mass index as a predictor of coronary calcification, coronary lesion and association with coronary artery tortuosity

    2021 · 2 citations
  51. Efficacy and Safety Outcomes of Short Duration Antiplatelet Therapy with Early Cessation of Aspirin Post Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis

    2021 · 2 citations
  52. TREATMENT RISK PARADOX IN NON ST ELEVATION ACUTE CORONARY SYNDROMES: IS IT A MATTER OF GENDER GAP?

    2020 · 2 citations
  53. Ethnic Differences in Protein Biomarkers of Peripartum Cardiomyopathy: A Proteomic Study on the EORP Cohort

    2025 · 1 citations
  54. Optimism Model by a Cardiology Pharmacist in Breaking Bad News Among Patients with CTRCD and its Impact on Outcomes

    2025 · 1 citations
  55. Abstract 18956: Knowledge of and Attitude Towards Clinical Trials Among Women in Rural Areas: A Survey-Based Study

    2023 · 1 citations
  56. Clinical Features, Socioeconomic Status, Management, and Outcomes of Acute Heart Failure: PEACE MENA Registry Phase I Results

    2023 · 1 citations
  57. Coronary angiographic profile in non ST elevation acute coronary syndrome: risk stratification and management strategy

    2023 · 1 citations
  58. International Registry of Cardiovascular diseases in Women (IROCW): Assessing the feasibility of large data registry in absence of funding and electronic database; initial data from Iraq

    2023 · 1 citations
  59. HEART TEAM WORK AT THE CARDIO-ONCOLOGY CLINIC FOR THE MANAGEMENT OF TRASTUZUMAB-RELATED CARDIOTOXICITY

    2023 · 1 citations
  60. The burden of Ischemic Heart Disease and the Epidemiologic Transition in the Eastern Mediterranean Region: 1990-2019

    2023 · 1 citations
  61. CRT-500.20 Barriers and Motivators for Participation of Cardiovascular Healthcare Providers in Clinical Trials in Iraq: A Survey-Based Study

    2023 · 1 citations
  62. CRT-100.98 International Registry of Cardiovascular Diseases in Women (IROCW): Assessing the Feasibility of Large Data Registry in the Absence of Funding and Electronic Database – Initial Data From Iraq

    2023 · 1 citations
  63. Global pattern of cardiovascular disease management in patients with cancer and impact of COVID-19 on drug selection: IRAQ—IC-OS survey-based study

    2022 · 1 citations
  64. Addressing Healthcare Disparities In The Scientific Contributions To The Heart Failure Society Of America Meetings: How Much Progress Did We Make?

    2022 · 1 citations
  65. TELEMEDICINE AND CARDIOLOGY PHARMACIST FOR SUPPORTING CARDIO-OBSTETRIC PATIENTS DURING COVID-19 LOCKDOWN

    2021 · 1 citations
  66. Prescription pattern of evidence-based pharmacotherapy in heart failure: An age perspective

    2021 · 1 citations
  67. Changing landscape of interventional cardiology practice in covid-19 era: A middle eastern perspective

    2021 · 1 citations
  68. Oral Anticoagulation in Heart Failure with Atrial Fibrillation: Are We Taking the Right Steps Towards Guidelines?

    2020 · 1 citations
  69. Adult Congenital Heart Diseases: Clinical Pattern, Management and Immediate Outcome in Ibn-Al-Bitar Center for Cardiac Surgery, Baghdad 2013

    2020 · 1 citations
  70. Large Right Atrial Myxoma Associated with Unexpected Large Abdominal Ascites

    2018 · 1 citations
  71. A CRUSADE-adjusted prospective cohort analysis of heparin dosing velocity, multivariable mediation and iatrogenic haemorrhage in acute coronary syndromes

    2026 · 0 citations
  72. Global Disparities in Diagnostic and Therapeutic Strategies for Myocardial Infarction With Non-obstructive Coronary Arteries: An International Survey

    2026 · 0 citations
  73. Cardio-obstetrics care: challenging scenarios in heart failure and future directions

    2026 · 0 citations
  74. Evaluate the role of the clinical pharmacist in improving quality indicators on initiation of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction in the cardiac unit

    2026 · 0 citations
  75. Global trend and predictors of non-labelled sacubitril–valsartan dosing: results from IKNOW-HF survey

    2026 · 0 citations
  76. Pregnancy in Women With Impaired Left Ventricular Function

    2026 · 0 citations
  77. Advancing cardiovascular imaging in Iraq: infrastructure, gender diversity, and future perspectives

    2026 · 0 citations
  78. Two-dimensional speckle-tracking echocardiography for detection of left ventricular diastolic dysfunction in hypertensive patients with preserved ejection fraction

    2026 · 0 citations
  79. Awareness, Willingness, and Concerns about Clinical Trial Participation among Iraqi Patients: A Cross-Sectional Study

    2026 · 0 citations
  80. Cancer Therapy-Related Cardiac Dysfunction, Risk Stratification, and Outcomes in ICOP Registry: First Data from the Arabian Middle East Region

    2026 · 0 citations
  81. Hyperkalemia-Associated GDMT De-optimization and Clinical Outcomes in Heart Failure: A Systematic Review and Dose-Response Meta-analysis

    2026 · 0 citations
  82. Targeting activated partial thromboplastin time of unfractionated heparin: the role of clinical pharmacist at the cardiac care unit

    2025 · 0 citations
  83. ROLE OF CARDIOLOGY CLINICAL PHARMACY SPECIALIST AND TELEMEDICINE IN THE DIAGNOSIS AND MANAGEMENT OF HYPERTENSION IN PATIENTS WITH CANCER AT THE CARDIO-ONCOLOGY CLINIC

    2025 · 0 citations
  84. 100.31 Geographic Disparities in Managing Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA)

    2025 · 0 citations
  85. Early detection of CTRCD by echocardiography among patients with breast cancer treated with anthracycline and trastuzumab stratified by HFA-ICOS risk classes

    2025 · 0 citations
  86. From Global Insights to National Impact: Advancing Cardio-Oncology in Iraq

    2024 · 0 citations
  87. Proteome profiling in patients with peripartum cardiomyopathy according to ethnicity a biomarker study on the EORP cohort

    2024 · 0 citations
  88. Role of the cardiology pharmacist in improving quality of care for patients with acute myocardial infarction based on ESC-ACCA quality indicators

    2024 · 0 citations
  89. HYPERTENSION IN CARDIO-ONCOLOGY: SURVEY AMONG CARDIOLOGY FELLOWS IN TRAINING

    2024 · 0 citations
  90. Availability, Volumes, and Referral Strategies of Advanced Heart Failure Therapies in the Eastern Mediterranean Region: Results from The AHF-EMR Survey

    2024 · 0 citations
  91. Impact of the role of cardiology pharmacy specialist on the improvement of quality indicators among patients with heart failure and reduced ejection fraction

    2023 · 0 citations
  92. Clopidogrel Responsiveness in Patients Undergoing Percutaneous Coronary Intervention using Multiplate Analyzer: Frequency and Outcomes

    2023 · 0 citations
  93. Barriers and Motivators for Participation of Cardiovascular Healthcare Providers in Clinical Trials in Iraq: A Survey-Based Study

    2023 · 0 citations
  94. International Registry of Cardiovascular Diseases in Women (IROCW): Assessing the Feasibility of Large Data Registry in the Absence of Funding and Electronic Database – Initial Data From Iraq

    2023 · 0 citations
  95. TCTAP A-097 International Registry of Cardiovascular Diseases in Women (IROCW): Assessing the Feasibility of Large Data Registry in the Absence of Funding and Electronic Database; Initial Data From Iraq

    2023 · 0 citations
  96. TCTAP A-085 Barriers and Motivators for Participation of Cardiovascular Healthcare Providers in Clinical Trials in Iraq: A Survey-Based Study

    2023 · 0 citations
  97. Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolic Events in Cancer Patients: A Meta-analysis of Randomized Controlled Trials

    2023 · 0 citations
  98. HFA-ICOS CARDIOVASCULAR RISK STRATIFICATION IN PATIENTS WITH BREAST CANCER ON TRASTUZUMAB: INITIAL DATA FROM THE CARDIO-ONCOLOGY CLINIC IN IRAQ

    2023 · 0 citations
  99. CANCER THERAPY RELATED CARDIAC DYSFUNCTION: FIRST YEAR DATA AND OUTCOME AT CARDIO-ONCOLOGY CLINIC IN IRAQ

    2023 · 0 citations
  100. Relationships between clinico-biochemical markers and echo parameter including right ventricle strain with severity of pulmonary arterial hypertension (group I) in Ibn-albitar cardiac center

    2023 · 0 citations

← Return to the university profile